Clare Craig on Medical Ethics

2:35 Mosquirix is a trade name for RTS,S/AS01:

In a bid to accommodate a larger group and guarantee a sustained availability for the general public, GSK applied for a marketing license with the European Medicines Agency (EMA) in July 2014. GSK treated the project as a non-profit initiative, with most funding coming from the Gates Foundation, a major contributor to malaria eradication.

In July 2015, Mosquirix received a positive scientific opinion from the European Medicines Agency on the proposal for the vaccine to be used to vaccinate children aged 6 weeks to 17 months outside the European Union. 

See also John Campbell on the UK Biobank Dataset and the BBC.

Subscribe to Clare Craig.

Comments

Popular posts from this blog

Steven Johnson - So You Think You Know How to Take Derivatives?

Hitachi HD44780U LCD Display Fonts

Using Pipewire to Make A Music Synthesizer